Cliquez ici pour connaître notre offre FCPI 2014

The fast pace of innovation in IT offers compelling investment opportunities

Truffle Capital is a pioneer investor in the exciting field of Energy

Biotechnology has radically transformed medicine over the past 25 years


Life Sciences

A number of factors have created an extremely favorable environment for investing in life sciences; among them, an aging population, a better understanding of disease mechanisms through the “biotechnology revolution”, cost containment policies in healthcare, the need by large pharmaceutical and medical device companies to renew their product pipelines, and the recent emergence of Europe as a desirable entrepreneurial and financial location for life sciences.

Biotechnology has radically transformed medicine over the last 25 years with breakthrough novel drugs, diagnostic methods and medical devices.
Truffle Capital’s Life Sciences team, headed by Philippe Pouletty, focuses on three areas: therapeutic drugs and vaccines, medical devices, and breakthrough technologies.

Click here to see our investments in the Life Sciences sector